CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
Ming Meng(Central South University), Sha Wang(Central South University), Wanpeng Wang(Xuzhou Medical College), Zeyu Wang(Anhui University), Hongshu Zhou(Central South University), Lu Chen(Army Medical University), Ye He(Central South University), Liyang Zhang(Central South University), Liting Yang(Central South University)
Cited by 6
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
|Journal of Hepatology|2021|215
A single-cell transcriptomic landscape of the lungs of patients with COVID-19
|Nature Cell Biology|2021|214